Manu Chandra's Sauce, the VC making a feast of small servingsSauce VC is set to make an estimated Rs 500-550 crore from L'Oréal's acquisition of Innovist, validating founder Manu Chandra's strategy of...
20 Jun, 2026, 06.00 AM IST
Reliance AGM 2026 Key Highlights: From Jio IPO, AI ventures to retail bets, check key announcements by Mukesh AmbaniRIL AGM 2026 Key Highlights: Reliance Industries Chairman Mukesh Ambani unveiled major plans at the company's annual general meeting. Key a...
19 Jun, 2026, 04.16 PM IST
Haldiram's new diner to bring mithai, namkeen to London's Leicester SquareHaldiram's is launching its first UK restaurant in London's Leicester Square next Thursday. The eatery aims to introduce Indian sweets and ...
18 Jun, 2026, 03.52 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
17 Jun, 2026, 03.08 PM IST
Fable 5 shock puts sovereign AI back on India’s agendaUS export controls on advanced AI models have spurred India's call for sovereign AI development. Industry leaders warn against reliance on ...
15 Jun, 2026, 06.00 AM IST
DBS optimistic about India’s long-term structural growth: Chief says country must invest in talent; focus on wealth spaceDBS Bank's CEO views India as a significant long-term growth opportunity. The nation can benefit from the AI-driven demand for hardware. Ho...
15 Jun, 2026, 05.30 AM IST
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
12 Jun, 2026, 12.25 PM IST
Six months on, National Sports Awards still await nodIndia's sporting community faces an unusual delay in the National Sports Awards. The Sports Ministry cites a re-evaluation of Arjuna awarde...
10 Jun, 2026, 02.38 PM IST
Tourism and hotel sector stocks: Time for a correction in business? Are analysts getting it wrong? 15 stocks from the ecosystemThe Indian hotel and tourism ecosystem has benefitted from the post-Covid travel urge. Occupancies were high, room rates firm, supply is, i...
10 Jun, 2026, 02.24 PM IST
More economic safeguards on the cards as West Asia conflict persists: ReportIndia is preparing new measures to protect its economy from the West Asia conflict. The government will introduce these steps gradually as ...
06 Jun, 2026, 12.29 PM IST
For a few dollars more: Inflation bypass can hurtIndia's central bank holds interest rates steady despite rising inflation. The focus shifts to stabilizing the rupee with a new dollar depo...
06 Jun, 2026, 12.16 AM IST
Collapse is near: Trump's window to resolve Iran crisis closing fastWest Asia tensions are escalating, impacting global markets. Iranian attacks and US strikes near the Strait of Hormuz are disrupting oil su...
04 Jun, 2026, 06.14 AM IST
MSMEs to bear bigger hit than large firms from West Asia conflict: CrisilThe ongoing crisis in West Asia has struck a harsh chord for Indian small enterprises, leaving them vulnerable to significant setbacks. Ant...
02 Jun, 2026, 07.33 PM IST
Volatility as opportunity, depends on framework of mind: 5 mid-caps from different sectors with upside potential of up to 31%The Indian stock market is no longer correcting only because of sentiment. It is now adjusting to the possibility of weaker numbers in the ...
02 Jun, 2026, 04.41 PM IST
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
02 Jun, 2026, 10.21 AM IST
Sensex falls over 400 points, Nifty below 23,250 amid US-Iran tensions, persistent FII sellingIndian stock markets experienced a significant downturn on Tuesday. Both the Sensex and Nifty indices saw substantial declines. This drop w...
02 Jun, 2026, 09.25 AM IST
Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
30 May, 2026, 11.17 PM IST